Wiebe C - Search Results

1

Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report.

Tambur AR, Bestard O, Campbell P, Chong AS, Barrio MC, Ford ML, Gebel HM, Heidt S, Hickey M, Jackson A, Kosmoliaptsis V, Lefaucheur C, Louis K, Mannon RB, Mengel M, Morris A, Pinelli DF, Reed EF, Schinstock C, Taupin JL, Valenzuela N, Wiebe C, Nickerson P. Tambur AR, et al. Among authors: wiebe c. Am J Transplant. 2023 Jan;23(1):133-149. doi: 10.1016/j.ajt.2022.11.009. Epub 2023 Jan 11. Am J Transplant. 2023. PMID: 36695615 Free article.

2

Exercise cardiac function in endurance-trained males versus females.

Wiebe CG, Gledhill N, Warburton DE, Jamnik VK, Ferguson S. Wiebe CG, et al. Clin J Sport Med. 1998 Oct;8(4):272-9. doi: 10.1097/00042752-199810000-00004. Clin J Sport Med. 1998. PMID: 9884791

3

Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.

Wiebe C, Gibson IW, Blydt-Hansen TD, Karpinski M, Ho J, Storsley LJ, Goldberg A, Birk PE, Rush DN, Nickerson PW. Wiebe C, et al. Am J Transplant. 2012 May;12(5):1157-67. doi: 10.1111/j.1600-6143.2012.04013.x. Epub 2012 Mar 19. Am J Transplant. 2012. PMID: 22429309 Free article. Clinical Trial.

4

Immune monitoring of kidney allografts.

Ho J, Wiebe C, Gibson IW, Rush DN, Nickerson PW. Ho J, et al. Among authors: wiebe c. Am J Kidney Dis. 2012 Oct;60(4):629-40. doi: 10.1053/j.ajkd.2012.01.028. Epub 2012 Apr 26. Am J Kidney Dis. 2012. PMID: 22542291

5

Increased urinary CCL2: Cr ratio at 6 months is associated with late renal allograft loss.

Ho J, Wiebe C, Rush DN, Rigatto C, Storsley L, Karpinski M, Gao A, Gibson IW, Nickerson PW. Ho J, et al. Among authors: wiebe c. Transplantation. 2013 Feb 27;95(4):595-602. doi: 10.1097/TP.0b013e31826690fd. Transplantation. 2013. PMID: 23192155

6

Posttransplant monitoring of de novo human leukocyte antigen donor-specific antibodies in kidney transplantation.

Wiebe C, Nickerson P. Wiebe C, et al. Curr Opin Organ Transplant. 2013 Aug;18(4):470-7. doi: 10.1097/MOT.0b013e3283626149. Curr Opin Organ Transplant. 2013. PMID: 23695596 Review.

7

Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes.

Wiebe C, Pochinco D, Blydt-Hansen TD, Ho J, Birk PE, Karpinski M, Goldberg A, Storsley LJ, Gibson IW, Rush DN, Nickerson PW. Wiebe C, et al. Am J Transplant. 2013 Dec;13(12):3114-22. doi: 10.1111/ajt.12478. Epub 2013 Oct 25. Am J Transplant. 2013. PMID: 24164958 Free article.

8

Elevated urinary CCL2: Cr at 6 months is associated with renal allograft interstitial fibrosis and inflammation at 24 months.

Ho J, Wiebe C, Gibson IW, Hombach-Klonisch S, Gao A, Rigatto C, Karpinski M, Storsley L, Nickerson PW, Rush DN. Ho J, et al. Among authors: wiebe c. Transplantation. 2014 Jul 15;98(1):39-46. doi: 10.1097/01.TP.0000442776.40295.73. Transplantation. 2014. PMID: 24646773

9

Acceptable mismatching at the class II epitope level: the Canadian experience.

Wiebe C, Nickerson P. Wiebe C, et al. Curr Opin Organ Transplant. 2014 Aug;19(4):442-6. doi: 10.1097/MOT.0000000000000104. Curr Opin Organ Transplant. 2014. PMID: 24977434 Review.

10

Antibody-mediated rejection: analyzing the risk, proposing solutions.

Arias M, Rush DN, Wiebe C, Gibson IW, Blydt-Hansen TD, Nickerson PW, Sellarés J, López-Hoyos M, San Segundo D, Crespo-Leiro MG, Marzoa-Rivas R, Barge-Caballero E, Paniagua-Martín MJ, Román A, Serón D, Böhmig G, Schwaiger E. Arias M, et al. Among authors: wiebe c. Transplantation. 2014 Aug 15;98 Suppl 3:S3-21. doi: 10.1097/TP.0000000000000218. Transplantation. 2014. PMID: 25093441 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

170 results

Search Page